Extracellular Vesicles
The general term for membrane-enclosed particles released by cells.
Exosomes are nanoscale, membrane-enclosed extracellular vesicles associated with the endosomal pathway. They form part of a broader system of intercellular communication through which cells release proteins, lipids, nucleic acids and other biologically active molecules.
Extracellular vesicles, commonly abbreviated as EVs, are membrane-bound particles released by cells into the extracellular environment. They do not contain a functional nucleus and cannot reproduce independently.
Exosomes are generally understood as EVs formed within the endosomal system and released when multivesicular bodies fuse with the plasma membrane.
Because the precise cellular origin of an isolated particle is often difficult to demonstrate, scientific guidance recommends the broader terms extracellular vesicle or small extracellular vesicle when endosomal biogenesis has not been established.
The general term for membrane-enclosed particles released by cells.
A size- or separation-based operational category commonly used when biological origin has not been directly demonstrated.
Extracellular vesicles associated specifically with formation inside endosomal multivesicular bodies.
Exosome formation is associated with the endosomal pathway. The process involves membrane remodelling, molecular cargo selection, intraluminal-vesicle formation and extracellular release.
The plasma membrane folds inward and contributes to the formation of early endosomal compartments.
Early endosomes mature while receiving membrane proteins, lipids and selected cellular components.
Sections of the endosomal membrane bud inward, creating small vesicles within multivesicular bodies.
Fusion of a multivesicular body with the plasma membrane releases its internal vesicles into the extracellular environment.
Extracellular-vesicle composition is influenced by the parent cell, physiological condition, passage number, culture medium, oxygen environment, collection method and downstream processing.
Extracellular-vesicle preparations may contain or display several classes of biological molecules.
Extracellular vesicles may influence recipient cells through several non-exclusive mechanisms.
Extracellular-vesicle signalling has been studied in normal biological processes including:
Extracellular vesicles are also investigated in pathological processes involving:
No single assay establishes that a preparation contains pure exosomes. Characterisation should combine complementary measurements of particle size, concentration, morphology, proteins, contaminants and biological function.
Nanoparticle tracking analysis or related systems may estimate particle concentration and size distribution.
Electron microscopy or other high-resolution imaging may demonstrate membrane-bound vesicular structures.
Protein assessment may examine selected transmembrane, membrane-associated and cytosolic EV-related markers.
Testing should consider soluble proteins, lipoproteins, protein aggregates and other co-isolated material.
Fit-for-purpose assays may evaluate the proposed biological activity or potency-related function of the preparation.
Source cells, passage number, culture conditions, collection, separation, storage and handling should be clearly documented.
Extracellular vesicles may be separated or enriched using differential centrifugation, ultracentrifugation, filtration, size-exclusion chromatography, density-gradient separation, affinity capture, precipitation or combinations of these methods.
These approaches differ in recovery, purity, scalability, processing time and suitability for downstream analytical or therapeutic development.
A high particle count does not by itself establish high purity, biological potency or clinical suitability.
Exosome and extracellular-vesicle research is active across mechanistic, diagnostic, drug-delivery and regenerative medicine applications. Evidence remains dependent on the specific biological source, manufacturing process and clinical indication.
Investigation of paracrine communication associated with tissue repair, angiogenesis, inflammation and cellular stress responses.
Study of how extracellular-vesicle-associated molecules may influence innate and adaptive immune responses.
Evaluation of circulating or tissue-derived extracellular vesicles as potential indicators of disease activity or treatment response.
Investigation of engineered or loaded vesicles for delivery of therapeutic molecules to selected tissues or cell populations.
Study of extracellular-vesicle signalling, neural communication and potential transport across biological barriers.
Development of reproducible culture, collection, purification, formulation, storage and potency-assessment methods.
Biological activity demonstrated in cell culture, laboratory models or animals does not by itself establish clinical safety or effectiveness in patients.
Extracellular-vesicle preparations produced by different laboratories cannot be assumed to be equivalent. Source cells, culture conditions, separation methods, formulation, dose, storage and route of administration may materially affect the final preparation.
Exosome or extracellular-vesicle preparations should not be described as established cures for neurological, autoimmune, metabolic, orthopaedic or other diseases without appropriate product-specific human evidence.
Evaluation begins with the identity, passage number, condition and culture environment of the originating cells.
Culture-media composition, conditioning period, collection method and pre-processing variables should be defined.
The selected process should reflect the intended purity, recovery, scale and downstream application.
Particle, morphology, protein, contaminant and functional data should be interpreted together.
Journal of Extracellular Vesicles. 2024;13:e12404.
View publicationJournal of Extracellular Vesicles. 2018;7(1):1535750.
View publicationJournal of Extracellular Vesicles. 2015;4:27066.
View publicationPhysicians, researchers and institutions may request additional information concerning EV characterisation, laboratory capabilities and scientific collaboration.